We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Experts are waking up to the threat posed by artificial intelligence programmes if they fall into malevolent hands
As NHS waiting lists grow, we want to know your experiences
Yogis brag about finding answers to life’s transcendental questions on their mats. Others find them in the saddle
Antitrust challenge may force big pharma groups to rethink ‘pure play’ business models
Drugmakers’ appetite for takeovers surges but FTC action against Amgen raises risks for megadeals
Pharmaceuticals producer in first court hearing on Monday
Escape into ancestral healing in the Mexican mountains, Crete on two wheels, and the art of Japanese flower arrangement
The infant nutrition business stays healthy when price rises bite as parents rarely trade down
Governments have promised to tackle the crisis for 25 years, but it’s never an election winner
Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
Information Commissioner’s Office calls for new regulation to avoid ethical breaches over handling of brain data
Pharmaceutical group says parts of law are unconstitutional
Healthcare groups call for reforms to pharma supply chains as up to half a million patients could be affected
Unsupervised generative AI could harm users and no one should risk their mental stability with ad hoc experimentation
Chic openings on the Spanish archipelago
Nobel Prize winner who discovered the cause of cervical cancer in humans
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Marketing attractive nicotine products to children risks a whole generation’s health
Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans
The tobacco company can justifiably claim expertise in developing alternative products that smokers will actually try
The leaked draft of the WHO Pandemic Accord contains worrying signs
Policy prescriptions are plentiful but momentum and money behind them is lacking
Cartels are cutting fentanyl with the cheap sedative, driving a surge in overdoses in cities such as Philadelphia
Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?
International Edition
